Objective: Lacosamide is an antiseizure agent and most commonly prescribed drugs for epilepsy. The aim of this work was evaluating the effect of Lacosamide (at its therapeutic range) on the kidney of pregnant albino rats.Methods: Forty pregnant rats were divided into two groups, group I received 1.5 ml/day distilled water in two divided doses throughout pregnancy. Rats in the group II received 1.5 ml/day distilled water (containing 36 mg Lacosamide) two divided doses. At the end of the experiment, blood samples were collected, and the sera were separated and used for biochemical analysis. The Kidneys were excised and examined by light and electron microscopic.Results: Treatment with Lacosamide induced undesirable histopathological changes in the kidney. These changes were in the form of fusion and effacement of secondary foot processes, thickening and disruption of the glomerular basement membrane, widening of the Bowman's spaces, cytoplasmic vacuolation, and swollen mitochondria with loss of their cristae. Such changes were confirmed by alteration of some biochemical parameters of kidney functions.Significance: Authors concluded that Lacosamide induced adverse effects on the kidney of pregnant albino rats. Further investigations are needed to identify the mechanism of Lacosamide toxicity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.